Zosano Pharma Corporation (ZSAN) Trading Down 1.4%

Shares of Zosano Pharma Corporation (NASDAQ:ZSAN) were down 1.4% during trading on Tuesday . The company traded as low as $0.57 and last traded at $0.68. Approximately 393,200 shares were traded during mid-day trading, a decline of 75% from the average daily volume of 1,570,178 shares. The stock had previously closed at $0.69.

Separately, ValuEngine upgraded Zosano Pharma Corporation from a “strong sell” rating to a “sell” rating in a research note on Friday, September 1st.

Zosano Pharma Corporation (NASDAQ:ZSAN) last issued its earnings results on Thursday, November 9th. The biotechnology company reported ($0.20) EPS for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.05). analysts forecast that Zosano Pharma Corporation will post -0.79 EPS for the current fiscal year.

A hedge fund recently raised its stake in Zosano Pharma Corporation stock. Northern Trust Corp boosted its holdings in shares of Zosano Pharma Corporation (NASDAQ:ZSAN) by 591.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 79,234 shares of the biotechnology company’s stock after purchasing an additional 67,774 shares during the quarter. Northern Trust Corp owned approximately 0.20% of Zosano Pharma Corporation worth $112,000 at the end of the most recent reporting period. 22.67% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “Zosano Pharma Corporation (ZSAN) Trading Down 1.4%” was reported by Markets Daily and is the sole property of of Markets Daily. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece of content can be accessed at https://www.themarketsdaily.com/2017/11/16/zosano-pharma-corporation-zsan-trading-down-1-4.html.

About Zosano Pharma Corporation

Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability.

Receive News & Ratings for Zosano Pharma Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zosano Pharma Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply